Market Cap 14.64M
Revenue (ttm) 2.07M
Net Income (ttm) -3.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -170.53%
Debt to Equity Ratio 0.00
Volume 27,900
Avg Vol 69,196
Day's Range N/A - N/A
Shares Out 4.33M
Stochastic %K 95%
Beta 1.79
Analysts Strong Buy
Price Target $8.00

Company Profile

Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. The company is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 327 8778
Address:
245 First Street, Riverview II, 18th Floor, Cambridge, United States
Bullbear1010101
Bullbear1010101 Jun. 13 at 4:41 PM
$CYCN anyone know if they still pursue TRD treatment ? doewnt matter thwt much since CYCN is only benefit by 1.5 percent of new Co
1 · Reply
CEMBP_Trader
CEMBP_Trader Jun. 11 at 9:37 AM
$CYCN Cost to borrow two months after reverse merger announced
0 · Reply
CEMBP_Trader
CEMBP_Trader Jun. 11 at 9:12 AM
$CYCN Cyclerion CVR (ii) with respect to Cyclerion’s right to receive payments under that License Agreement, dated June 3, 2021, between Cyclerion and Akebia Therapeutics, Inc. (the “Akebia License Agreement”), the earlier of (A) the fifteenth (15th) anniversary of the date of entry into the Cyclerion CVR Agreement and (B) the expiration pursuant to its terms or earlier termination by Akebia of the Akebia License Agreement, and (iii) with respect to the sale, transfer or other disposition of the equity interests of Tisento Therapeutics Holdings, Inc. (“Tisento”) beneficially owned by Cyclerion, the earliest of (A) nine (9) months following the date of the consummation of Tisento’s initial public offering pursuant to a registration statement filed with, and declared effective by, the Securities and Exchange Commission pursuant to the Securities Act, (B) the sale of Tisento, and (C) the seventh (7th) anniversary of the Closing Date.
0 · Reply
CEMBP_Trader
CEMBP_Trader Jun. 11 at 8:59 AM
$CYCN S-4/A dated 6/9/26 “On March 19, 2026, Terrence McGuire on behalf of the board of directors of Tisento, contacted Dr. Graul with an unsolicited offer to purchase all equity securities of Tisento beneficially owned by Cyclerion … the Cyclerion Board determined that the purchase price offered in the Tisento Proposal was not an acceptable price for 10% of the equity interests of Tisento … The Cyclerion Board directed … Cyclerion’s management to identify potential transactions and interested counterparties for the sale of the equity securities of Tisento beneficially owned by Cyclerion.“ 7/31/23 Cyclerion PR “Tisento is launching with an $81 million Series A financing … CYCLERION received 10 percent equity ownership in Tisento with anti-dilution protection through $100 million in post-money valuation, as well as the right to purchase additional Tisento equity in the future. ” 1/8/26 Tisento PR “company expects to report top-line data from the study in the fourth quarter of 2026.”
1 · Reply
Sw1ngb0t
Sw1ngb0t May. 23 at 5:38 PM
$CYCN $2.39 is baked in... we'll see it's ready for us then
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 21 at 1:19 AM
$CYCN $1.50 then $11
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 12:17 PM
$CYCN bizarre chart... I love it. $2 might be a good entry... we'll see
0 · Reply
shock89
shock89 May. 11 at 2:12 PM
0 · Reply
SuperGreenToday
SuperGreenToday May. 11 at 10:33 AM
0 · Reply
shock89
shock89 May. 9 at 12:16 AM
$LRHC Hope we can get 10k and DA soon! Then it will squeeze like $FLZH $SKK $CYCN
0 · Reply
Latest News on CYCN
Cyclerion Therapeutics files $25M mixed securities shelf

2025-02-04T21:45:08.000Z - 1 year ago

Cyclerion Therapeutics files $25M mixed securities shelf


Biotech Alert: Searches spiking for these stocks today

2024-11-18T15:55:13.000Z - 1 year ago

Biotech Alert: Searches spiking for these stocks today

TFFP


Cyclerion Therapeutics appoints Regina Graul as CEO

2024-08-07T11:26:09.000Z - 2 years ago

Cyclerion Therapeutics appoints Regina Graul as CEO


Regina Graul, Ph.D., Promoted to Chief Executive Officer

Aug 7, 2024, 7:00 AM EDT - 2 years ago

Regina Graul, Ph.D., Promoted to Chief Executive Officer


Cyclerion Therapeutics appoints Graul as President

2023-12-04T13:04:15.000Z - 2 years ago

Cyclerion Therapeutics appoints Graul as President


Cyclerion Appoints Regina Graul, Ph.D., as President

Dec 4, 2023, 8:00 AM EST - 2 years ago

Cyclerion Appoints Regina Graul, Ph.D., as President


Cyclerion Announces Reverse Stock Split

May 15, 2023, 1:00 PM EDT - 3 years ago

Cyclerion Announces Reverse Stock Split


Cyclerion Therapeutics to Host Pipeline Update Webinar

Apr 20, 2021, 7:00 AM EDT - 5 years ago

Cyclerion Therapeutics to Host Pipeline Update Webinar


Bullbear1010101
Bullbear1010101 Jun. 13 at 4:41 PM
$CYCN anyone know if they still pursue TRD treatment ? doewnt matter thwt much since CYCN is only benefit by 1.5 percent of new Co
1 · Reply
CEMBP_Trader
CEMBP_Trader Jun. 11 at 9:37 AM
$CYCN Cost to borrow two months after reverse merger announced
0 · Reply
CEMBP_Trader
CEMBP_Trader Jun. 11 at 9:12 AM
$CYCN Cyclerion CVR (ii) with respect to Cyclerion’s right to receive payments under that License Agreement, dated June 3, 2021, between Cyclerion and Akebia Therapeutics, Inc. (the “Akebia License Agreement”), the earlier of (A) the fifteenth (15th) anniversary of the date of entry into the Cyclerion CVR Agreement and (B) the expiration pursuant to its terms or earlier termination by Akebia of the Akebia License Agreement, and (iii) with respect to the sale, transfer or other disposition of the equity interests of Tisento Therapeutics Holdings, Inc. (“Tisento”) beneficially owned by Cyclerion, the earliest of (A) nine (9) months following the date of the consummation of Tisento’s initial public offering pursuant to a registration statement filed with, and declared effective by, the Securities and Exchange Commission pursuant to the Securities Act, (B) the sale of Tisento, and (C) the seventh (7th) anniversary of the Closing Date.
0 · Reply
CEMBP_Trader
CEMBP_Trader Jun. 11 at 8:59 AM
$CYCN S-4/A dated 6/9/26 “On March 19, 2026, Terrence McGuire on behalf of the board of directors of Tisento, contacted Dr. Graul with an unsolicited offer to purchase all equity securities of Tisento beneficially owned by Cyclerion … the Cyclerion Board determined that the purchase price offered in the Tisento Proposal was not an acceptable price for 10% of the equity interests of Tisento … The Cyclerion Board directed … Cyclerion’s management to identify potential transactions and interested counterparties for the sale of the equity securities of Tisento beneficially owned by Cyclerion.“ 7/31/23 Cyclerion PR “Tisento is launching with an $81 million Series A financing … CYCLERION received 10 percent equity ownership in Tisento with anti-dilution protection through $100 million in post-money valuation, as well as the right to purchase additional Tisento equity in the future. ” 1/8/26 Tisento PR “company expects to report top-line data from the study in the fourth quarter of 2026.”
1 · Reply
Sw1ngb0t
Sw1ngb0t May. 23 at 5:38 PM
$CYCN $2.39 is baked in... we'll see it's ready for us then
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 21 at 1:19 AM
$CYCN $1.50 then $11
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 12:17 PM
$CYCN bizarre chart... I love it. $2 might be a good entry... we'll see
0 · Reply
shock89
shock89 May. 11 at 2:12 PM
0 · Reply
SuperGreenToday
SuperGreenToday May. 11 at 10:33 AM
0 · Reply
shock89
shock89 May. 9 at 12:16 AM
$LRHC Hope we can get 10k and DA soon! Then it will squeeze like $FLZH $SKK $CYCN
0 · Reply
BillionerOfKing
BillionerOfKing May. 5 at 2:33 AM
$CYCN Current Stock Price: $3.26
1 · Reply
TheRealShortSqueezy
TheRealShortSqueezy May. 4 at 4:03 PM
$CELZ : Momentum Building as Breakthrough Data Fuels Renewed Interest 🧬 Creative Medical Technology Holdings is gaining attention after its April 28 breakthrough, reporting a 93% response rate in its Ultrasome knee osteoarthritis program. Strong clinical results combined with improving price action are starting to bring momentum back to the story. Technical View: 🔸 Tight consolidation with buyers stepping in on dips 🔸 Higher lows forming, showing strength 🔸 Price compressing beneath resistance Key Levels to Watch: 📈 $2.02 🟰 Key support 📈 $2.21–$2.51 🟰 Current consolidation range 📈 $2.74 🟰 Breakout level 📈 $3.08–$3.34 🟰 Major resistance zone 📈 $3.86 🟰 High timeframe resistance With strong clinical momentum and multiple catalysts ahead, CELZ is targeting $100B+ markets, positioning itself for increased attention as the story continues to unfold. Communicated Disclaimer: https://tinyurl.com/TherealshortsqueezyCELZ1 Sector Peers: $CYCN $DYAI $MBRX $AIXC
1 · Reply
Bullbear1010101
Bullbear1010101 May. 1 at 1:19 AM
$CYCN Guess i dont want to search .. but anyone know if insiders sold 7-8 on that pump
0 · Reply
FonsieTrader
FonsieTrader Apr. 29 at 9:44 PM
$CYCN 👀 Quietly setting up again. After the spike → consolidation holding above $2.80–$3.00. No panic selling, structure staying tight. TTM Squeeze cooling off → reset phase. MFI recovering → buyers stepping back in. If this reclaims $3.40–$3.50 with volume… this can push for another leg. Not dead. Just loading.
2 · Reply
FonsieTrader
FonsieTrader Apr. 29 at 9:41 PM
$CYCN 👀 Quietly setting up again. After the spike → consolidation holding above $2.80–$3.00. No panic selling, structure staying tight. TTM Squeeze cooling off → reset phase. MFI recovering → buyers stepping back in. If this reclaims $3.40–$3.50 with volume… this can push for another leg. Not dead. Just loading.
0 · Reply
Oscarthesuperstar1
Oscarthesuperstar1 Apr. 29 at 2:46 PM
$CYCN Bottom could be in, making this a very attractive price and time to buy
0 · Reply
Lifefinder
Lifefinder Apr. 28 at 7:45 PM
$CYCN I think we have a winner
1 · Reply
Lifefinder
Lifefinder Apr. 28 at 5:44 PM
$CYCN maybe today
0 · Reply
ShortTheStock
ShortTheStock Apr. 26 at 8:39 AM
$CYCN short it lovely
1 · Reply
EZYME22
EZYME22 Apr. 24 at 12:55 AM
$CYCN what thesis remains here? gotta be a pump coming?
2 · Reply
Whitewasabi
Whitewasabi Apr. 23 at 7:12 PM
$CYCN this will probably pump soon
0 · Reply
TheZymeth
TheZymeth Apr. 22 at 7:39 PM
$CYCN time to accumulate while this is silent! 🤫
0 · Reply